- Reaction score
- 969
Yes this will probably be the most important update so far from the company since:
1) They will finally release Phase III data from WinLevi (same thing as Breezula but with a smaller %). If it gets approved I think it will be much easier for them to continue with Breezula and release it.
2) They will know for sure if Breezula works or not and if it is safe since it is a big trial with about 400 people. Hopefully they will start Phase III next year as they state on their website.
So hypothetical it’ll be out in 2025 for alopecia. Topical antiandrogen in 2025.
Just think about it for a second.
Topical antiandrogen in 2025.
Topical antiandrogen in 2025.
Topical antiandrogen in 2025.
God lord tsuji, please help us. Q